Skip to content

Omeros

US · OMER #3062 by market cap Listed 1970
13.21 -0.80 -5.71%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Company notice
    4: Omeros | 4: Statement of changes in beneficial ownership of securities-Director Hood Leroy E. MD PhD
    SEC · 2026/6/22
  • Cantor Fitzgerald Maintains Omeros(OMER.US) With Buy Rating, Maintains Target Price $22
    Market Newswire · 2026/10/14
  • Company notice
    4: Omeros | 4: Statement of changes in beneficial ownership of securities-Officer Borges David J.
    SEC · 2026/7/25
  • Rating change
    Omeros Is Maintained at Buy by D. Boral Capital
    Dow Jones · 2026/4/21
  • Company notice
    Omeros | 4: Statement of changes in beneficial ownership of securities-Officer Borges David J.
    SEC · 2026/9/25
  • Company notice
    4: Omeros | 4: Statement of changes in beneficial ownership of securities-Director Cable Thomas J.
    SEC · 2026/6/22
  • H.C. Wainwright Maintains Omeros(OMER.US) With Buy Rating, Maintains Target Price $33
    Market Newswire · 2026/10/17
  • Rating change
    OMER S.p.A.: Resilient Fundamentals and Structural Growth Support Buy Rating Despite Softer FY26 Outlook
    TipRanks · 2026/4/3
  • Omeros Q2 Adj. EPS $0.02 Beats $(0.27) Estimate, Sales $28.529M Beat $12.700M Estimate
    Benzinga · 2026/8/13
  • Rating change
    H.C. Wainwright Maintains Omeros(OMER.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/6/10
  • Rating change
    WBB Securities Maintains Omeros(OMER.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2026/1/8
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), PepGen Inc. (PEPG) and Omeros (OMER)
    TipRanks · 2026/4/1
  • Rating change
    HC Wainwright & Co. Maintains Buy on Omeros, Lowers Price Target to $33
    Benzinga · 2026/6/26
  • Company notice
    4: Omeros | 4: Statement of changes in beneficial ownership of securities-Director Perkinson Diana T.
    SEC · 2026/6/22
  • Rating change
    Omeros Price Target Maintained With a $36.00/Share by D. Boral Capital
    Dow Jones · 2026/4/21
  • Cantor Fitzgerald Initiates Omeros(OMER.US) With Buy Rating, Announces Target Price $22
    Market Newswire · 2026/9/22
  • Needham Maintains Omeros(OMER.US) With Hold Rating
    Market Newswire · 2026/8/13
  • Rating change
    Needham Maintains Omeros(OMER.US) With Hold Rating, Announces Target Price $10.72
    Market Newswire · 2026/6/26
  • Rating change
    D. Boral Capital Maintains Buy on Omeros, Maintains $36 Price Target
    Benzinga · 2026/1/27
  • Rating change
    H.C. Wainwright Maintains Omeros(OMER.US) With Buy Rating, Cuts Target Price to $33
    Market Newswire · 2026/6/27
  • H.C. Wainwright Maintains Omeros(OMER.US) With Buy Rating, Maintains Target Price $33
    Market Newswire · 2026/8/13
  • Rating change
    Omeros Is Maintained at Buy by HC Wainwright & Co.
    Dow Jones · 2026/1/8

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.

Omeros discussion 0 comments

Add a comment